Italy vs Netherlands: Access to anti-retroviral drugs, female
Italy
89.0%
in 2023
Netherlands
89.0%
in 2023
Italy rank
35th
Netherlands rank
35th
Access to anti-retroviral drugs, female over time
- Italy
- Netherlands
How they compare
Italy currently reports 89.0% against 89.0% in Netherlands, a difference of 0.0%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Netherlands ahead.
Italy ranks 35th and Netherlands ranks 35th of 141 countries.
Across the 3 decades both report, Italy averaged higher in 2 and Netherlands in 1.
Head to head by decade
| Decade | Italy | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.5% | 62.9% | 10.4% | Netherlands |
| 2010s | 81.0% | 77.7% | 3.3% | Italy |
| 2020s | 89.2% | 86.8% | 2.5% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Italy or Netherlands?
- Italy, at 89.0% against 89.0% in Netherlands as of 2023.
- What is the difference in access to anti-retroviral drugs, female between Italy and Netherlands?
- 0.0%, with Italy ahead.
- How many years of comparable data are there for Italy and Netherlands?
- 24 years are reported by both, from 2000 to 2023.
- How do Italy and Netherlands rank globally for access to anti-retroviral drugs, female?
- Italy ranks 35th and Netherlands ranks 35th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.